Moderator: Catherine Rogers Murray, MPH (she/her/hers) – Exponent, Inc.
### she/her/hers @@@ Emilie D. Duchesneau, PhD, MSPH (she/her/hers) – Department of Epidemiology and Prevention, Wake Forest School of Medicine ### 2325307###Moderator###Assistant Professor###Department of Epidemiology and Prevention, Wake Forest School of Medicine###Moderator: Emilie D. Duchesneau, PhD, MSPH (she/her/hers) – Department of Epidemiology and Prevention, Wake Forest School of Medicine
### she/her/hersModerator: Tanja Mueller, PhD, MPH, FHEA (she/her/hers) – University of Strathclyde
### she/her/hers @@@ Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1655344###Moderator###Assistant Professor###University of North Carolina at Chapel Hill###Moderator: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/hisLead Speaker: Olivier Humblet, ScD (he/him/his) – Regeneron Pharmaceuticals
### he/him/his @@@ Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1093999###Speaker###Chief Science Officer###Aetion, Inc.###Speaker: Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real-World Evidence###European Medicines Agency###Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Uwe Siebert, MPH, MSc, ScD (he/him/his) – UMIT TIROL - University for Health Sciences and Technology ### 2325382###Speaker###Chair, Dept. of Public Health, Health Services Research and Health Technology Assessment###UMIT TIROL - University for Health Sciences and Technology###Speaker: Uwe Siebert, MPH, MSc, ScD (he/him/his) – UMIT TIROL - University for Health Sciences and Technology
### he/him/his @@@ Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals ### 1360408###Speaker###Sr. Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###Speaker: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals
### he/him/hisPresenting Author: James W. Antoon, MD, PhD, MPH – Vanderbilt University Medical Center
### @@@ Derek J. williams, MD, MPH – Vanderbilt University Medical Center ### 1658421###Co-Author###Associate Professor###Vanderbilt University Medical Center###Co-Author: Derek J. williams, MD, MPH – Vanderbilt University Medical Center
### @@@ Jean Bruce – Department of Health Policy, Vanderbilt University Medical Center ### 1993063###Co-Author###Database Administrator###Department of Health Policy, Vanderbilt University Medical Center###Co-Author: Jean Bruce – Department of Health Policy, Vanderbilt University Medical Center
### @@@ Mert Sekmen – VUMC Division of Pediatric Hospital Medicine ### 1993064###Co-Author######VUMC Division of Pediatric Hospital Medicine###Co-Author: Mert Sekmen – VUMC Division of Pediatric Hospital Medicine
### @@@ Yuwei Zhu, MD, MS – Vanderbilt University Medical Center ### 1993065###Co-Author###Senior Associate in Biostatistics###Vanderbilt University Medical Center###Co-Author: Yuwei Zhu, MD, MS – Vanderbilt University Medical Center
### @@@ Carlos G. Grijalva, MD MPH FIDSA – Department of Health Policy, Vanderbilt University Medical Center ### 1063183###Co-Author###Professor, Health Policy###Department of Health Policy, Vanderbilt University Medical Center###Co-Author: Carlos G. Grijalva, MD MPH FIDSA – Department of Health Policy, Vanderbilt University Medical Center
###